Open AccessPeer review of the pesticide risk assessment for the active substance flumioxazin in light of negligible exposure data submitted
Author(s) -
Arena Maria,
Auteri Domenica,
Barmaz Stefania,
Brancato Alba,
Brocca Daniela,
Bura Laszlo,
Carrasco Cabrera Luis,
Chiusolo Arianna,
Civitella Consuelo,
Court Marques Daniele,
Crivellente Federica,
Ctverackova Lucie,
De Lentdecker Chloe,
Egsmose Mark,
Erdos Zoltan,
Fait Gabriella,
Ferreira Lucien,
Greco Luna,
Ippolito Alessio,
Istace Frederique,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lostia Alfonso,
Lythgo Christopher,
Magrans Jose Oriol,
Medina Paula,
Mineo Desire,
Miron Ileana,
Molnar Tunde,
Padovani Laura,
Parra Morte Juan Manuel,
Pedersen Ragnor,
Reich Hermine,
Sacchi Angela,
Santos Miguel,
Serafimova Rositsa,
Sharp Rachel,
Stanek Alois,
Streissl Franz,
Sturma Juergen,
Szentes Csaba,
Tarazona Jose,
Terron Andrea,
Theobald Anne,
Vagenende Benedicte,
Van Dijk Joanke,
VillamarBouza Laura
Publication year - 2018
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2018.5415
Subject(s) - european commission , risk assessment , commission , environmental health , medicine , european union , business , political science , law , computer security , computer science , economic policy
The conclusions of EFSA following the peer review of the initial risk assessment carried out by the competent authority of the rapporteur Member State, Czech Republic, for the pesticide active substance flumioxazin are reported. The European Commission requested EFSA to conduct a peer review and provide its conclusions on whether exposure of humans to flumioxazin can be considered negligible, taking into account the European Commission's draft guidance on this topic. The conclusions were reached on the basis of the evaluation of the representative uses of flumioxazin as a herbicide on winter wheat and sunflower (pre‐ and post‐emergence). The reliable endpoints, derived from the studies and the literature data presented in the dossier and considered appropriate for use in regulatory risk assessment, are presented.